Similarities and important distinctions between drug and behavioral intervention development
Discover Psychology · 22.04.2025 · 5 (1)
DOI: 10.1007/s44202-025-00352-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Discover Psychology, online erschienen am 22.04.2025. Verfasst von Hannah M Fisher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute.
Abstract (Originalsprache)
There has been a proliferation in behavioral intervention development due to guidelines recommending their use for managing common, distressing, and interfering symptoms (e.g., insomnia, pain, fatigue) resulting from medical disease (e.g., cancer) and its treatment. Several models of behavioral intervention development exist (e.g., Stage Model, ORBIT). In this review, we focus on the National Institute of Health (NIH) Stage Model for Behavioral Intervention Development because it offers the closest analogue to the formalized drug development process. This review compares the phases of drug development to the six stages of the Stage Model for behavioral intervention development to assist investigators in understanding similarities and differences in terminology (i.e., Phase versus Stage), study designs and methods, and ultimate purpose. Distinguishing features of the NIH Stage Model for behavioral intervention development are highlighted and include: (1) a recursive and iterative flow; and (2) a focus on intervention mechanisms at every stage of development. To illustrate each stage, we refer to a program of research developing and testing a behavioral insomnia and symptom (e.g., pain, fatigue) management intervention for patients with life-threatening hematologic cancer. This illustrative example conveys the initial steps required to develop and pilot test a behavioral intervention before progressing to larger-scale efficacy and effectiveness testing. To conclude, we offer recommendations for investigators designing and testing behavioral interventions. Recommendations are first, develop a long-term research plan that begins with the end in mind, and second, ensure each step in the research plan provides sufficient information to proceed to the next stage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC USA.
- Duke Cancer Institute, Durham, NC USA.
- Pain Prevention and Treatment Research Program, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, 2400 Pratt Street, Room 7056, Durham, NC 27705 USA.
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC USA.
Förderung
- National Cancer Institute
Zitieren
APA
Fisher, H. M., Winger, J. G., Samsa, G. P., & Somers, T. J. (2025). Similarities and important distinctions between drug and behavioral intervention development. Discover Psychology, 5(1). https://doi.org/10.1007/s44202-025-00352-5
Vancouver
Fisher HM, Winger JG, Samsa GP, Somers TJ. Similarities and important distinctions between drug and behavioral intervention development. Discover Psychology. 2025;5(1). doi:10.1007/s44202-025-00352-5
BibTeX
@article{Fisher2025,
author = {Fisher, Hannah M and Winger, Joseph G and Samsa, Gregory P and Somers, Tamara J},
title = {Similarities and important distinctions between drug and behavioral intervention development},
journal = {Discover Psychology},
year = {2025},
volume = {5},
number = {1},
doi = {10.1007/s44202-025-00352-5}
}
EUVIMED